Cue Health Inc.

HLTHQ Healthcare Health Information Services

Cue Health Inc.’s revenue for fiscal 2023 (year ended December 2023) was $70.9 million, down 85.3% from fiscal 2022.

0.00 0.00 NaN
Market cap
$6.9M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
2/9
Altman Z
−5.66
Beneish M
n/a
Dividend safety
n/a
Dec '23 Sep '23 Jun '23 Mar '23 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.50 0.32 0.22 0.84
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(1.22) (5.02) (1.32) (5.10)
P/B ratio
0.14 0.16 0.13 0.55
Price to Tangible BV
0.15 0.17 0.14 0.58
EV/Sales
(0.65) (0.25) (0.29) 0.29
EV/EBITDA
0.14 0.21 0.31 0.00
EV/Operating CF
0.33 0.30 0.39 (0.49)
EV/FCF
0.29 0.26 0.32 (0.38)
Quick Ratio
1.91 1.94 2.30 2.80
Current Ratio
2.54 3.29 3.72 4.25
Net Debt/EBITDA
0.63 2.20 1.77 2.13
Debt/Assets
0.00% 0.00% 0.00% 0.07%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.14 0.30 0.35 0.41
Operating CF/Net income
0.19 0.27 0.51 0.57
Capex/Depreciation
(0.10) (0.27) (0.48) (0.69)
Interest Coverage
(432.86) (212.85) (293.45) (435.68)
Research and Development Expense of Revenue
171.55% 212.30% 369.20% 180.63%
Selling, General and Administrative Expense of Revenue
85.60% 131.02% 230.01% 113.81%
Intangible Assets out of Total Assets
0.06 0.04 0.04 0.03
Share Based Compensation of Revenue
53.93% 72.59% 116.24% 58.17%
Graham Net Nets
0.59 1.41 1.98 0.63
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(1,060.87%) (412.20%) (494.59%) (107.14%)
Free Cash Flow Yield
(448.24%) (299.67%) (410.76%) (92.60%)
Revenue per Share
0.12 0.11 0.07 0.16
Operating CF per Share
(0.19) (0.08) (0.28) (0.36)
Capex per Share
(0.01) (0.02) (0.04) (0.06)
Free Cash Flow per Share
(0.20) (0.11) (0.32) (0.41)
Cash per Share
0.53 0.73 0.85 1.18
Shareholders Equity per Share
1.64 2.53 2.79 3.28
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
1.64 2.53 2.79 3.28
Free Cash Flow
(30.55) (16.20) (48.65) (62.20)
Working Capital
66.90 133.83 155.05 219.54
Capital Expenditures
(1.83) (3.66) (5.99) (8.32)
Net Current Asset Value
20.83 88.78 111.39 174.30
EV/EBIT
0.12 0.17 0.25 0.00
Capex to Sales
0.10 0.21 0.61 0.34
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
10.05 13.05 27.86 42.81
Average Payables
7.43 21.82 24.78 32.74
Average Inventory
48.12 98.43 103.71 107.29
Average Assets
517.18 658.66 718.97 796.17
Average Common Equity
413.37 489.40 531.78 610.50

Fold the line items

Columns are period end dates